AstraZeneca to acquire Fusion Pharmaceuticals to boost cancer radioconjugate development
In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a pioneer in the development of ... Read More
Amylyx Pharmaceuticals’ AMX0035 misses primary and secondary endpoints in ALS study
Cambridge, Massachusetts-based Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a key player in the pharmaceutical industry, announced today the top-line results of the PHOENIX study, a critical ... Read More
PCM Trials to enhance decentralized clinical trials with EmVenio Research acquisition
In a significant move to advance decentralized clinical trials (DCTs), Denver-based PCM Trials, the leading independent provider of mobile research nurse visits for DCTs, has ... Read More
Testing laboratories firm Labcorp to spin off clinical development business
Labcorp, an American testing laboratories company, said that its board of directors has authorized it to undertake a spin-off of its fully-owned clinical development business ... Read More
Infosys to acquire Denmark-based BASE life science in €110m deal
Infosys has signed a deal worth up to €110 million to acquire BASE life science, a Denmark-based technology and consulting company in the life sciences ... Read More
Pharmacy store giant Walgreens forays into clinical trial business
American pharmacy store chain Walgreens has launched its clinical trial business with the aim of redefining the patient experience and boosting access and retention in ... Read More
Lilly to launch real-world Covid-19 study of bamlanivimab in New Mexico
Eli Lilly and Company (Lilly), a global leader in the pharmaceutical industry, has announced plans to conduct a new pragmatic study of its experimental Covid-19 ... Read More
Boston Scientific’s LUMINIZE RF Balloon Catheter shows promising results in AF-FICIENT I trial
Boston Scientific has announced that its LUMINIZE Radiofrequency (RF) Balloon Catheter, developed for isolating pulmonary veins (PVs) in atrial fibrillation (AF) treatment, has demonstrated positive ... Read More
Nordic Nanovector launches US Phase 2b trial for Betalutin in follicular lymphoma
Nordic Nanovector, a Norwegian biopharmaceutical company, has commenced the first clinical site in the United States for its PARADIGME trial. This pivotal trial is designed ... Read More
Quotient Sciences opens new $15m facility in Garnet Valley to boost drug development capabilities
Quotient Sciences, a UK-based drug development services provider, has inaugurated a new early phase formulation and manufacturing plant in Garnet Valley, Pennsylvania. The facility, spanning ... Read More